Ron Cohen, President and CEO, Acorda Therapeutics, Inc.

Ron Cohen, President and CEO, Acorda Therapeutics, Inc.

Type: 
Video

Dr. Cohen discusses the plight of today’s emerging biotech companies, and how the federal government can best support innovation within the industry so that the U.S. remains globally competitive. Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with MS, spinal cord injury and other neurological conditions.